- Merit Medical Systems, Inc. (MMSI, Financial) records significant revenue growth with an impressive operating margin in Q1 2025.
- The company's stock has promising upside potential, according to Wall Street analysts.
- GuruFocus estimates suggest a potential downside in the stock's fair value over the next year.
Merit Medical Systems, Inc. (MMSI) reported a stellar performance for the first quarter of 2025, achieving a revenue milestone of $355.4 million. This marks an impressive 9.8% increase compared to the same period last year. Notably, the company achieved a record-setting 19.3% non-GAAP operating margin. Despite challenges from new tariff impacts, Merit Medical forecasts a strong revenue growth trajectory of 8% to 10% for the year 2025.
Wall Street Analysts Forecast
Analyst insights are bullish on Merit Medical Systems Inc (MMSI, Financial), with 10 analysts offering a one-year price target that averages $117.20. This projection reflects a potential upside of 23.80% from its current trading price of $94.67. Price targets range from a low estimate of $111.00 to a high of $128.00. For more in-depth analysis, visit the Merit Medical Systems Inc (MMSI) Forecast page.
Furthermore, the consensus among 11 brokerage firms positions Merit Medical Systems Inc (MMSI, Financial) with an average brokerage recommendation of 1.7, denoting an "Outperform" status. The rating scale ranges from 1, indicating a strong buy, to 5, signifying a sell.
GuruFocus Analysis
According to GuruFocus estimates, the GF Value of Merit Medical Systems Inc (MMSI, Financial) in the next year is projected at $89.56. This suggests a potential downside of 5.4% from the current market price of $94.67. The GF Value is calculated by considering the historical multiples at which the stock has traded, past business growth, and future performance projections. For a comprehensive breakdown, visit the Merit Medical Systems Inc (MMSI) Summary page.
